← Back to headlines
Halozyme Partners with Incyte for Enhanze Technology Use
Halozyme has announced a deal with Incyte to utilize its Enhanze technology for a candidate targeting neoplasms.
20 Jul, 12:48 — 20 Jul, 12:48
Sources
Showing 1 of 1 sources
